367 related articles for article (PubMed ID: 10998653)
1. Gastrointestinal carcinoids: characterization by site of origin and hormone production.
Onaitis MW; Kirshbom PM; Hayward TZ; Quayle FJ; Feldman JM; Seigler HF; Tyler DS
Ann Surg; 2000 Oct; 232(4):549-56. PubMed ID: 10998653
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal carcinoid tumors: factors that predict outcome.
Van Gompel JJ; Sippel RS; Warner TF; Chen H
World J Surg; 2004 Apr; 28(4):387-92. PubMed ID: 14994141
[TBL] [Abstract][Full Text] [Related]
3. Foregut carcinoids: a clinical and biochemical analysis.
Kirshbom PM; Kherani AR; Onaitis MW; Hata A; Kehoe TE; Feldman C; Feldman JM; Tyler DS
Surgery; 1999 Dec; 126(6):1105-10. PubMed ID: 10598194
[TBL] [Abstract][Full Text] [Related]
4. Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids.
Kirshbom PM; Kherani AR; Onaitis MW; Feldman JM; Tyler DS
Surgery; 1998 Dec; 124(6):1063-70. PubMed ID: 9854584
[TBL] [Abstract][Full Text] [Related]
5. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.
Janson ET; Holmberg L; Stridsberg M; Eriksson B; Theodorsson E; Wilander E; Oberg K
Ann Oncol; 1997 Jul; 8(7):685-90. PubMed ID: 9296223
[TBL] [Abstract][Full Text] [Related]
6. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors.
Shebani KO; Souba WW; Finkelstein DM; Stark PC; Elgadi KM; Tanabe KK; Ott MJ
Ann Surg; 1999 Jun; 229(6):815-21; discussion 822-3. PubMed ID: 10363895
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and carcinoid tumors.
Ahlman H
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S79-85. PubMed ID: 2412066
[TBL] [Abstract][Full Text] [Related]
8. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
Rorstad O
J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
[TBL] [Abstract][Full Text] [Related]
9. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin.
Jaffee IM; Rahmani M; Singhal MG; Younes M
Arch Pathol Lab Med; 2006 Oct; 130(10):1522-6. PubMed ID: 17090195
[TBL] [Abstract][Full Text] [Related]
10. 7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.
Perez EA; Koniaris LG; Snell SE; Gutierrez JC; Sumner WE; Lee DJ; Hodgson NC; Livingstone AS; Franceschi D
World J Surg; 2007 May; 31(5):1022-30. PubMed ID: 17429568
[TBL] [Abstract][Full Text] [Related]
11. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors.
Eriksson B; Bergström M; Lilja A; Ahlström H; Långström B; Oberg K
Acta Oncol; 1993; 32(2):189-96. PubMed ID: 7686763
[TBL] [Abstract][Full Text] [Related]
13. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
[TBL] [Abstract][Full Text] [Related]
14. Carcinoid tumors in the gastrointestinal tract--an analysis of 156 cases.
Mårtensson H; Nobin A; Sundler F
Acta Chir Scand; 1983; 149(6):607-16. PubMed ID: 6650073
[TBL] [Abstract][Full Text] [Related]
15. Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors.
Al-Khafaji B; Noffsinger AE; Miller MA; DeVoe G; Stemmermann GN; Fenoglio-Preiser C
Hum Pathol; 1998 Sep; 29(9):992-9. PubMed ID: 9744317
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal carcinoid tumors: long-term prognosis for surgically treated patients.
Söreide JA; van Heerden JA; Thompson GB; Schleck C; Ilstrup DM; Churchward M
World J Surg; 2000 Nov; 24(11):1431-6. PubMed ID: 11038218
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal carcinoids and the malignant carcinoid syndrome.
Beaton H; Homan W; Dineen P
Surg Gynecol Obstet; 1981 Mar; 152(3):268-72. PubMed ID: 7466571
[TBL] [Abstract][Full Text] [Related]
18. Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors.
Kema IP; de Vries EG; Slooff MJ; Biesma B; Muskiet FA
Clin Chem; 1994 Jan; 40(1):86-95. PubMed ID: 7507008
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature.
Tsoukalas N; Chatzellis E; Rontogianni D; Alexandraki KI; Boutzios G; Angelousi A; Kaltsas G
Medicine (Baltimore); 2017 Apr; 96(16):e6201. PubMed ID: 28422824
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors.
Srivastava A; Hornick JL
Am J Surg Pathol; 2009 Apr; 33(4):626-32. PubMed ID: 19065104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
